Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Mar 15;134(6):611–613.

Segmental pulmonary consolidation due to amiodarone.

P Gibb, L J Melendez
PMCID: PMC1490918  PMID: 3948074

Full text

PDF
611

Images in this article

611Fig. 1
on p.611
612Fig. 2
on p.612
612Fig. 3
on p.612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Darmanata J. I., van Zandwijk N., Düren D. R., van Royen E. A., Mooi W. J., Plomp T. A., Jansen H. M., Durrer D. Amiodarone pneumonitis: three further cases with a review of published reports. Thorax. 1984 Jan;39(1):57–64. doi: 10.1136/thx.39.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fogoros R. N., Anderson K. P., Winkle R. A., Swerdlow C. D., Mason J. W. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation. 1983 Jul;68(1):88–94. doi: 10.1161/01.cir.68.1.88. [DOI] [PubMed] [Google Scholar]
  3. Greene H. L., Graham E. L., Werner J. A., Sears G. K., Gross B. W., Gorham J. P., Kudenchuk P. J., Trobaugh G. B. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol. 1983 Dec;2(6):1114–1128. doi: 10.1016/s0735-1097(83)80338-6. [DOI] [PubMed] [Google Scholar]
  4. Haffajee C. I., Love J. C., Canada A. T., Lesko L. J., Asdourian G., Alpert J. S. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation. 1983 Jun;67(6):1347–1355. doi: 10.1161/01.cir.67.6.1347. [DOI] [PubMed] [Google Scholar]
  5. Marchlinski F. E., Gansler T. S., Waxman H. L., Josephson M. E. Amiodarone pulmonary toxicity. Ann Intern Med. 1982 Dec;97(6):839–845. doi: 10.7326/0003-4819-97-6-839. [DOI] [PubMed] [Google Scholar]
  6. Marcus F. I., Fontaine G. H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J. 1981 Apr;101(4):480–493. doi: 10.1016/0002-8703(81)90140-x. [DOI] [PubMed] [Google Scholar]
  7. McKenna W. J., Rowland E., Krikler D. M. Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) 1983 Dec 3;287(6406):1654–1656. doi: 10.1136/bmj.287.6406.1654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nademanee K., Singh B. N., Hendrickson J., Intarachot V., Lopez B., Feld G., Cannom D. S., Weiss J. L. Amiodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med. 1983 May;98(5 Pt 1):577–584. doi: 10.7326/0003-4819-98-5-577. [DOI] [PubMed] [Google Scholar]
  9. Rakita L., Sobol S. M., Mostow N., Vrobel T. Amiodarone pulmonary toxicity. Am Heart J. 1983 Oct;106(4 Pt 2):906–916. doi: 10.1016/0002-8703(83)90015-7. [DOI] [PubMed] [Google Scholar]
  10. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  11. Rotmensch H. H., Liron M., Tupilski M., Laniado S. Possible association of pneumonitis with amiodarone therapy. Am Heart J. 1980 Sep;100(3):412–413. doi: 10.1016/0002-8703(80)90165-9. [DOI] [PubMed] [Google Scholar]
  12. van Zandwijk N., Darmanata J. I., Düren D. R., Alberts C., Durrer D., Wagenvoort C. A. Amiodarone pneumonitis. Eur J Respir Dis. 1983 May;64(4):313–317. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES